Quest Diagnostics Incorporated
| Security | DGX / Quest Diagnostics Incorporated |
| Insider | Denise M Morrison |
This page shows the track record and history of MORRISON DENISE M
insider trades in Quest Diagnostics Incorporated. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Denise M Morrison in DGX / Quest Diagnostics Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Denise M Morrison in DGX / Quest Diagnostics Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | 2026-05-20 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,142 | 11,929 | ||||||
| 2025-05-19 | 2025-05-15 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,203 | 10,742 | ||||||
| 2024-05-20 | 2024-05-16 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,482 | 9,490 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,369 | 7,955 | ||||||
| 2022-05-20 | 2022-05-18 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,292 | 6,540 | ||||||
| 2021-05-25 | 2021-05-25 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,363 | 5,206 | ||||||
| 2020-05-21 | 2020-05-19 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,531 | 3,783 | ||||||
| 2019-10-02 | 2019-10-01 | 4 | MORRISON DENISE M | DGX | Phantom Stock Units | D | 0.00 | 264 | 1,026 | |||||
| 2019-07-02 | 2019-07-01 | 4 | MORRISON DENISE M | DGX | Phantom Stock Units | D | 0.00 | 275 | 755 | |||||
| 2019-05-16 | 2019-05-14 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 1,722 | 2,212 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | MORRISON DENISE M | DGX | Phantom Stock Units | D | 0.00 | 90.6000 | 311 | 28 | 474 | |||
| 2019-02-20 | 2019-02-18 | 4 | MORRISON DENISE M | DGX | Phantom Stock Units | D | 0.00 | 86.6300 | 163 | 14 | 163 | |||
| 2019-02-20 | 2019-02-18 | 4 | MORRISON DENISE M | DGX | Common Stock | D | 484 | 484 |
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)
